RecruitingNCT05169333
The Oxford Risk Factors And Non-Invasive Imaging Study
Sponsor
University of Oxford
Enrollment
250,000 participants
Start Date
Feb 23, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Inclusion Criteria3
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 -99 years.
- Male or Female, aged 18 -99 years.
Exclusion Criteria4
- Unable or unwilling to consent
- Active cancer
- Participation in Study Arms 1, 2 or 3
- Existing opt-out from use of data for research purposes
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(37)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05169333
Related Trials
Diabetes and Heart Disease Risk in Blacks
NCT000018531 location
Hypertension Explored in Long-term Postpartum Follow-up in Later Life
NCT061870121 location
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731152 locations
SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation
NCT068867891 location
Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
NCT058814471 location